+49 2066 50687-70

Publications

abstractspublicationsEN
Fast identification of disseminated mucormycosis in hematooncologic patients by next-generation sequencing: a case series.

Invasive mucormycoses are increasingly emerging and a severe health threat with potentially fatal outcome especially for immunocompromised patients. They are challenging to diagnose: the diagnostic workup includes numerous tests, is time-intensive and frequently invasive. Cultivation is difficult and slow and yet frequently remains negative. Fast diagnosis for a timely treatment is urgently needed. We here describe a case series, where untargeted next-generation sequencing (NGS, with Noscendo’s CE-IVD marked DISQVER® pathogen test) provided identification of moulds in three patients with underlying hematologic malignancies from a standard blood draw within 24h after sample arrival.

abstractspublicationsEN
Pathogen detection by metagenomic next-generation sequencing during neutropenic fever in patients with haematological malignancies

Febrile neutropenia (FN) following chemotherapy is a major cause of morbidity requiring urgent use of broad-spectrum antibiotics. Blood culture (BC) is a standard diagnostic method for FN but sensitivity of pathogen detection is low. Timely identification of causative pathogens using metagenomic next-generation sequencing (mNGS) of circulating cell-free DNA (cfDNA) from plasma could reduce morbidity and costs by enabling early-targeted antimicrobial therapy. The aim of this study is to establish mNGS (DISQVER) for the detection of pathogens within 24h in immunocompromised haematological patients with FN

Information for physicians

More precise diagnostics – more knowledge: Find out more about the clinical use of DISQVER!

How DISQVER works

Information for medical disciplines

Publications

News

Read more about Noscendo and DISQVER or visit us at trade fairs and conferences!

All News

Publications

Events

Press

Company

DISQVER together – get to know Noscendo!

Noscendo

Team

Advisory Board

Career